A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults

A Randomized, Open-label, 2-period, 2-sequence, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of AD-230 in Healthy Adult Volunteers

A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults

Inclusion Criteria:

• Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
• Subjects aged 19 years or older and under 65 years at the screening visit

Exclusion Criteria:

• Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
• Other exclusions applied